USA. Massachusetts Bridge Clinics Reduce Barriers to Starting Medication for Opioid Use Disorder
USA. Massachusetts Bridge Clinics Reduce Barriers to Starting Medication for Opioid Use Disorder
Effective treatments for substance use disorder (SUD) can substantially improve patient outcomes. First-line medications like buprenorphine and methadone can decrease opioid fatality rates, infectious disease transmission, and other adverse health consequences,[1] yet barriers to accessing these medications persist, from insufficient program capacity, long wait times, to inadequate support during high-risk transitions, such as emergency department discharge and release from prison and jail.
These challenges have spurred interest in the creation of new, low-barrier models to streamline the induction of medications to treat opioid use disorder (OUD) induction and SUD care delivery, such as bridge clinics. (Addiction Policy Forum, USA, 07.06.2024)
https://www.addictionpolicy.org/post/massachusetts-bridge-clinics-reduce-barriers-to-starting-medication-for-opioid-use-disorder